The low levels of gravity (microgravity) in space cause significant changes in astronauts’ eyes and vision after six to 12 months aboard the International Space Station (ISS), according to a study.
Researchers from NYU Langone Health and NYU Grossman School of Medicine are part of a major undertaking that will bring together more than 40 scientists, doctors, and industry experts from around the ...
("VisiRose" or the "Company"), a privately-held, clinical-stage biotechnology company developing novel ocular therapeutics, today announced a $3 million seed financing round for VisiRose ...
The experiment was part of the PSLV Orbital Experiment Module (POEM-4 ... The footage highlights the satellite’s advanced imaging capabilities and readiness for the mission’s next phase.